1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Athlete's Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015

Athlete's Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Athlete's Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015" provides data on the Athlete’s Foot (Tinea Pedis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Athlete’s Foot (Tinea Pedis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Athlete’s Foot (Tinea Pedis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Athlete's Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Athlete's Foot (Tinea Pedis) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Athlete's Foot (Tinea Pedis) to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Athlete's Foot (Tinea Pedis) to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Athlete's Foot (Tinea Pedis) 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials 27
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Sun Pharmaceutical Industries Limited 29
Clinical Trial Overview of Sun Pharmaceutical Industries Limited 29
Merz Pharma GmbH and Co. KgaA 30
Clinical Trial Overview of Merz Pharma GmbH and Co. KgaA 30
Valeant Pharmaceuticals International, Inc. 31
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 31
York Pharma Plc (Inactive) 32
Clinical Trial Overview of York Pharma Plc (Inactive) 32
Tinea Pharmaceuticals 33
Clinical Trial Overview of Tinea Pharmaceuticals 33
Exeltis USA, Inc. 34
Clinical Trial Overview of Exeltis USA, Inc. 34
AmDerma Pharmaceuticals, LLC. 35
Clinical Trial Overview of AmDerma Pharmaceuticals, LLC. 35
Perrigo Company plc 36
Clinical Trial Overview of Perrigo Company plc 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
NB Therapeutics, Inc. 38
Clinical Trial Overview of NB Therapeutics, Inc. 38
Clinical Trial Overview of Top Institutes / Government 39
National Institute of Siddha 39
Clinical Trial Overview of National Institute of Siddha 39
Guangdong Provincial Hospital of Traditional Chinese Medicine 40
Clinical Trial Overview of Guangdong Provincial Hospital of Traditional Chinese Medicine 40
Oita University 41
Clinical Trial Overview of Oita University 41
Jamaica Hospital Medical Center 42
Clinical Trial Overview of Jamaica Hospital Medical Center 42
The Hong Kong Polytechnic University 43
Clinical Trial Overview of The Hong Kong Polytechnic University 43
Hillel Yaffe Medical Center 44
Clinical Trial Overview of Hillel Yaffe Medical Center 44
Five Key Clinical Profiles 45
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 70
Contact Us 71
Disclaimer 71
Source 71

List of Tables

Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 13
Proportion of Athlete's Foot (Tinea Pedis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 14
Athlete's Foot (Tinea Pedis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Athlete's Foot (Tinea Pedis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Athlete's Foot (Tinea Pedis) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 17
Athlete's Foot (Tinea Pedis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Athlete's Foot (Tinea Pedis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Athlete's Foot (Tinea Pedis) Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Athlete's Foot (Tinea Pedis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2015* 29
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH and Co. KgaA, 2015* 30
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 31
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by York Pharma Plc (Inactive), 2015* 32
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tinea Pharmaceuticals, 2015* 33
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Exeltis USA, Inc., 2015* 34
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by AmDerma Pharmaceuticals, LLC., 2015* 35
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Perrigo Company plc, 2015* 36
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by NB Therapeutics, Inc., 2015* 38
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Siddha, 2015* 39
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Provincial Hospital of Traditional Chinese Medicine, 2015* 40
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oita University, 2015* 41
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Jamaica Hospital Medical Center, 2015* 42
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hong Kong Polytechnic University, 2015* 43
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillel Yaffe Medical Center, 2015* 44

List of Figures

Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 13
Proportion of Athlete's Foot (Tinea Pedis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 14
Athlete's Foot (Tinea Pedis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Athlete's Foot (Tinea Pedis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Athlete's Foot (Tinea Pedis) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 17
Athlete's Foot (Tinea Pedis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Athlete's Foot (Tinea Pedis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Athlete's Foot (Tinea Pedis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Athlete's Foot (Tinea Pedis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Athlete's Foot (Tinea Pedis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Antifungal Drugs: Technologies and Global Markets

Antifungal Drugs: Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Evaluate the effect of strategic factors such as technology-driven change and industry consolidation on the antifungal drugs market. - Investigate the current market dynamics and ...

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global antifungal drugs market was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key ...

Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dermatophytic Onychomycosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Gastrointestinal Drug Industry in Canada

  • March 2017
    92 pages
  • Gastrointestina...  

    Health Care Pro...  

    Ambulatory Care  

  • Canada  

    North America  

View report >

Gastrointestinal Drug Industry in Canada

  • March 2017
    92 pages
  • Gastrointestina...  

    Health Care Pro...  

    Ambulatory Care  

  • Canada  

    North America  

View report >

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

Antiseptics Markets

4 months ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.